BARDA

3D rendering of SARS-CoV-2 virus particles
Research

COVID antibodies shut down variants, earn $35M BARDA bucks

To “box in” SARS-CoV-2, researchers made multispecific antibodies that neutralize COVID strains and prevent the virus from evolving escape methods.
Darren Incorvaia Oct 9, 2024 2:00pm
Experienced laboratory scientist analyzing a botulism sample from a canned food can

GigaGen garners up to $135M BARDA bucks to beat botulism

Oct 3, 2024 8:00am
Antibiotic-resistant bacteria

Basilea scores $268M BARDA funding for antifungals, antibiotics

Sep 19, 2024 7:45am
Walgreens store

Walgreens, BARDA ink 5-year decentralized clinical trials deal

Aug 19, 2024 10:27am
An artists impression of influenza molecules The molecules are blue and have multicolored centers

Tiba wins BARDA contract to develop RNAi flu therapeutics

Jul 11, 2024 3:35pm
pandemic COVID-19 flu

Allucent selected for new BARDA decentralized trial initiative

Jul 10, 2024 5:00am